HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system.

Abstract
Increasing numbers of plant-made vaccines and pharmaceuticals are entering the late stage of product development and commercialization. Despite the theoretical benefits of such production, expression of parasite antigens in plants, particularly those from Plasmodium, the causative parasites for malaria, have achieved only limited success. We have previously shown that stable transformation of tobacco plants with a plant-codon optimized form of the Plasmodium yoelii merozoite surface protein 4/5 (PyMSP4/5) gene resulted in PyMSP4/5 expression of up to approximately 0.25% of total soluble protein. In this report, we describe the rapid expression of PyMSP4/5 in Nicotiana benthamiana leaves using the deconstructed tobacco mosaic virus-based magnICON expression system. PyMSP4/5 yields of up to 10% TSP or 1-2 mg/g of fresh weight were consistently achieved. Characterization of the recombinant plant-made PyMSP4/5 indicates that it is structurally similar to PyMSP4/5 expressed by Escherichia coli. It is notable that the plant-made PyMSP4/5 protein retained its immunogenicity following long-term storage at ambient temperature within freeze-dried leaves. With assistance from a mucosal adjuvant the PyMSP4/5-containing leaves induced PyMSP4/5-specific antibodies when delivered orally to naïve mice or mice primed by a DNA vaccine. This study provides evidence that immunogenic Plasmodium antigens can be produced in large quantities in plants using the magnICON viral vector system.
AuthorsDiane E Webster, Lina Wang, Mark Mulcair, Charles Ma, Luca Santi, Hugh S Mason, Steve L Wesselingh, Ross L Coppel
JournalPlant biotechnology journal (Plant Biotechnol J) Vol. 7 Issue 9 Pg. 846-55 (Dec 2009) ISSN: 1467-7652 [Electronic] England
PMID19781007 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Malaria Vaccines
  • Membrane Proteins
  • Protozoan Proteins
  • Vaccines, DNA
  • merozoite surface protein 4, Plasmodium
  • merozoite surface protein 5
Topics
  • Animals
  • Antibodies, Protozoan (blood)
  • Antigens, Protozoan (biosynthesis, immunology)
  • Female
  • Genetic Vectors
  • Malaria Vaccines (immunology)
  • Membrane Proteins (biosynthesis, immunology)
  • Mice
  • Mice, Inbred BALB C
  • Plants, Genetically Modified (genetics, metabolism)
  • Plasmodium (genetics)
  • Protozoan Proteins (biosynthesis, immunology)
  • Nicotiana (genetics, metabolism)
  • Tobacco Mosaic Virus (genetics)
  • Vaccines, DNA (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: